Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06350500 · ClinicalTrials.gov registry record · NA

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

A NA study of Breast Carcinoma and Breast Ductal Carcinoma In Situ, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
126
Enrollment target
1
Study location

NCT06350500: Recruiting NA study of Breast Carcinoma and Breast Ductal Carcinoma In Situ, sponsored by Roswell Park Cancer Institute.

NCT06350500 is a NA study of Breast Carcinoma and Breast Ductal Carcinoma In Situ that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 126 participants, below the 769-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06350500, a NA study of Breast Carcinoma and Breast Ductal Carcinoma In Situ, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients.

Primary Outcome

Enrollment rate Will be defined as the number of patients enrolled divided by the number of patients approached. The enrollment rate will be estimated with a 90% credible region obtained by Jeffrey's prior method.

Interventions

  • OTHER Questionnaire
  • BEHAVIORAL Patient Navigation

Study Locations (1)

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2024-12-15
Est. Completion 2028-03-15
Phase NA
Roswell Park Cancer Institute

365 total trials

What NCT06350500 shows while recruiting

NCT06350500 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 769-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.

NCT06350500 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06350500 about?

NCT06350500 is a clinical study titled "A Patient Navigation Program for Addressing Disparities in Breast Cancer Care". This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance pati...

What is the current status of trial NCT06350500?

This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-12-15. Estimated completion is 2028-03-15.

What conditions does trial NCT06350500 study?

This clinical trial studies the following conditions: Breast Carcinoma, Breast Ductal Carcinoma In Situ.

What interventions are being tested in trial NCT06350500?

The interventions under investigation include: Questionnaire (OTHER), Patient Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06350500?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06350500 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06350500's enrollment target sits among peer trials

126 54th of 106 higher than 53 of 106 other Breast Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06350500, the US trial registry maintained by the National Library of Medicine. NCT06350500 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.